Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Weavering, FATCA dominate fund governance discussions according to directors' poll

Friday, April 12, 2013

Bailey McCann, Opalesque New York:

In an era of new regulations, fund governance is a hot topic for funds and investors alike. The AIFMD will come into force in July, just a few short months away, and the new US tax regime - FATCA, is on the horizon for January. As the guidance surrounding these new rules unfolds, a recent survey sheds light onto how stakeholders are approaching the new requirements.

DMS Offshore, the leader in fund governance recently conducted its first ever poll of fund directors to get a sense of what issues are driving decisions. "The poll really captures the crux of the conversations happening around governance," says Kathleen Celoria, executive director, DMS Offshore in an interview with Opalesque. "A lot of people are turning their attention to FATCA now, and it's really the next big thing on the horizon."

In the poll, respondents noted changes in the way institutional investors are doing due diligence and approaching fund governance overall. According to the data, 2012 saw an increase in the number of on-site visits, and interviews institutions are completing as part of their due diligence review. The questions institutions are asking have also changed, investors are placing a greater focus on transparency, reporting, and notably, how independence is defined when it comes to fund directors. Data shows that institutions often......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner